Tandem Diabetes Care, Inc. recalls Tandem pumps are battery-operated…
Tandem Diabetes Care, Inc. recalls Tandem pumps are battery-operated infusion pumps capable of both ba…
- Published
- 1 Apr 2026
- Units affected
- 1,380 units
- Agency
- FDA
- Country
- United States
The hazard
The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead direct users to confirm that the infusion set is not connected to the body. Following this instruction could result in unintended insulin delivery, potentially leading to a hypoglycemic event.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize a motor-driven mechanism to deliver insulin from within a disposable cartridge, through an infusion set, into a patient s subcutaneous tissue. As with current insulin infusion pumps on the U.S. market, the desired timing and quantity of the insulin delivery is programmed by the user (i.e., the patient).
- Brand / company
- Tandem Diabetes Care, Inc.
- Codes / lots
- Version 7.8.1/ UDI: (01)008500066132625
- Distribution
- International distribution in the countries of Czech Republic, Slovakia.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 1 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.